MedPath

PREDNISOLONE/SULFACETAMIDE

PREDNISOLONE/SULFACETAMIDE

Dormant
DIN Number

02023814

Drug Class

Human

Market Date

Dec 31, 1994

Company
HC

pharma stulln inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02023814
AIG Number0206094002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01CA02 PREDNISOLONE AND ANTIINFECTIVES
Product Specifications
Dosage FormSuspension
Route of AdministrationOphthalmic
AHFS Classification52:08.08
Health Canada Classification

ACTIVE INGREDIENTS (2)

PREDNISOLONE ACETATEActive
Strength: 0.5 % / W/V
Monograph: PREDNISOLONE ACETATE
SULFACETAMIDE SODIUMActive
Strength: 10 % / W/V
Monograph: SULFACETAMIDE SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.